SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-19-003854
Filing Date
2019-11-29
Accepted
2019-11-29 13:20:12
Documents
6
Period of Report
2019-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k-112619.htm 8-K 29644
2 FORM OF WARRANT sonoma_8k-ex0401.htm EX-4.1 75100
3 LEGAL OPINION sonoma_8k-ex0501.htm EX-5.1 15109
4 PLACEMENT AGENCY AGREEMENT sonoma_8k-ex1001.htm EX-10.1 195915
5 GRAPHIC image_001.jpg GRAPHIC 6840
6 GRAPHIC image_002.jpg GRAPHIC 3014
  Complete submission text file 0001683168-19-003854.txt   330820
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 191260740
SIC: 2834 Pharmaceutical Preparations